ZNTL- Zentalis Pharmaceuticals, Inc.

Name: Zentalis Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Zentalis Pharmaceuticals, Inc. (ZNTL) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 31 sells. ZNTL is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Walters Group	13.51M	$49.58M	-
10%	Matrix Capital Management Company, LP	6.46M	$23.71M	-
Other	Vultaggio Vincent	146.5K	$537.7K	-
Other	Bucher James B	100.0K	$367.0K	-
CEO	Eastland Julia Marie	79.1K	$290.4K	-

Activity

Buys and sells only

Transactions

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 4, 2022	Epperly Melissa B,72	Chief Financial Officer	Sell	17,080	$50.09	$855,522.43	-1.3%	-41.3%	-66.5%
Mar 21, 2022	Bunker Kevin D.78	Chief Operating Officer	Sell	10,000	$49.07	$490,669.87	-3.4%	-51.1%	-62.5%
Mar 15, 2022	Gallagher Cam81	Director	Sell	10,000	$41.92	$419,241.28	-0.9%	-50.0%	-57.3%
Mar 10, 2022	Bunker Kevin D.78	Chief Operating Officer	Sell	10,000	$46.94	$469,374.23	-2.1%	-41.0%	-65.5%
Mar 7, 2022	Gallagher Cam81	Director	Sell	10,000	$44.94	$449,387.24	-1.3%	-41.6%	-58.5%
Mar 2, 2022	Sun Anthony Y81	President &CEO	Sell	20,942	$49.98	$1,046,649.00	-0.4%	-51.6%	-61.6%
Feb 23, 2022	Epperly Melissa B,72	Chief Financial Officer	Sell	1,913	$49.10	$93,920.75	-0.4%	-56.5%	-59.7%
Feb 22, 2022	Bunker Kevin D.78	Chief Operating Officer	Sell	10,000	$49.09	$490,933.31	-1.5%	-56.6%	-60.5%
Feb 15, 2022	Gallagher Cam81	Director	Sell	10,000	$51.93	$519,294.68	-0.9%	-53.7%	-61.3%
Feb 14, 2022	Gallagher Cam81	Director	Sell	7,188	$50.19	$360,774.92	-0.6%	-51.2%	-59.9%

← PrevPage 6Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC